-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on RAPT Therapeutics, Raises Price Target to $72

Benzinga·11/03/2025 14:11:17
Listen to the news
Wells Fargo analyst Yanan Zhu maintains RAPT Therapeutics (NASDAQ:RAPT) with a Overweight and raises the price target from $48 to $72.